Full-service decentralized clinical trial vendors can offer sponsors virtual (remote-based), traditional (brick-and-mortar), and hybrid site participation in their clinical studies. This flexibility in supporting site participation can be pivotal in running a widely accessible and successful trial.
Regardless of the type of site model a study utilizes, one idea remains. Co-creation between DCT vendors and sponsors with the incorporation of sites’ input is imperative to achieving an effective and sustainable trial design.
Learn more about how co-creation works from Curebase.